2.92
Lineage Cell Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
FY22:
14.0
FY23:
8.27
FY24:
9.17
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−49.2
FY22:
−22.5
FY23:
−24.7
FY24:
−21.5
FY25:
−36.6
(positive)
Change from FY22 to FY24
millions USD
FY21:
–
FY22:
−19.8
FY23:
−23.9
FY24:
−22.7
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.3
FY22:
−25.8
FY23:
−23.3
FY24:
−18.6
FY25:
−68.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.0
FY22:
−26.3
FY23:
−21.5
FY24:
−18.6
FY25:
−63.5
All amounts in millions USD